![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dimethylhydrazine | increases expression | ISO | RGD:1318509 | 6480464 | 1, 2-Dimethylhydrazine results in increased expression of SLAIN1 mRNA | CTD | PMID:22206623 | 17beta-estradiol | multiple interactions | ISO | RGD:1603921 | 6480464 | [Estradiol co-treated with TGFB1 protein] results in decreased expression of SLAIN1 mRNA | CTD | PMID:30165855 | 2,3',4,4',5-Pentachlorobiphenyl | increases expression | ISO | RGD:1318509 | 6480464 | 2 more ... | CTD | PMID:31388691 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SLAIN1 mRNA | CTD | PMID:34747641 | 2,4-dibromophenyl 2,4,5-tribromophenyl ether | decreases expression | ISO | RGD:1603921 | 6480464 | 2 more ... | CTD | PMID:26705709 | 4,4'-sulfonyldiphenol | decreases methylation | ISO | RGD:1603921 | 6480464 | bis(4-hydroxyphenyl)sulfone results in decreased methylation of SLAIN1 gene | CTD | PMID:31601247 | 4,4'-sulfonyldiphenol | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of SLAIN1 mRNA | CTD | PMID:36041667 | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of SLAIN1 mRNA | CTD | PMID:24780913 | aflatoxin B1 | decreases methylation | ISO | RGD:1603921 | 6480464 | Aflatoxin B1 results in decreased methylation of SLAIN1 gene | CTD | PMID:27153756 | aflatoxin M1 | decreases expression | ISO | RGD:1603921 | 6480464 | Aflatoxin M1 results in decreased expression of SLAIN1 mRNA | CTD | PMID:30928695 | all-trans-retinoic acid | decreases expression | ISO | RGD:1318509 | 6480464 | Tretinoin results in decreased expression of SLAIN1 mRNA | CTD | PMID:16788091 | all-trans-retinoic acid | decreases expression | ISO | RGD:1603921 | 6480464 | Tretinoin results in decreased expression of SLAIN1 mRNA | CTD | PMID:33167477 | amphetamine | decreases expression | EXP | | 6480464 | Amphetamine results in decreased expression of SLAIN1 mRNA | CTD | PMID:30779732 | antirheumatic drug | decreases expression | ISO | RGD:1603921 | 6480464 | Antirheumatic Agents results in decreased expression of SLAIN1 mRNA | CTD | PMID:24449571 | aristolochic acid A | decreases expression | ISO | RGD:1603921 | 6480464 | aristolochic acid I results in decreased expression of SLAIN1 mRNA | CTD | PMID:33212167 | arsenous acid | decreases expression | ISO | RGD:1603921 | 6480464 | Arsenic Trioxide results in decreased expression of SLAIN1 mRNA | CTD | PMID:26705709 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of SLAIN1 mRNA | CTD | PMID:25181051 more ... | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of SLAIN1 mRNA | CTD | PMID:36041667 | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of SLAIN1 gene | CTD | PMID:28505145 | bisphenol F | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of SLAIN1 mRNA | CTD | PMID:36041667 | buta-1,3-diene | decreases expression | ISO | RGD:1318509 | 6480464 | 1, 3-butadiene results in decreased expression of SLAIN1 mRNA | CTD | PMID:29038090 | cadmium atom | multiple interactions | ISO | RGD:1603921 | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SLAIN1 mRNA | CTD | PMID:35301059 | cadmium dichloride | decreases expression | EXP | | 6480464 | Cadmium Chloride results in decreased expression of SLAIN1 mRNA | CTD | PMID:33453195 | cadmium dichloride | multiple interactions | ISO | RGD:1603921 | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SLAIN1 mRNA | CTD | PMID:35301059 | copper atom | multiple interactions | ISO | RGD:1603921 | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of SLAIN1 mRNA | CTD | PMID:20971185 | copper(0) | multiple interactions | ISO | RGD:1603921 | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of SLAIN1 mRNA | CTD | PMID:20971185 | crocidolite asbestos | increases methylation | ISO | RGD:1603921 | 6480464 | Asbestos, Crocidolite results in increased methylation of SLAIN1 gene | CTD | PMID:29523930 | cyclosporin A | increases expression | ISO | RGD:1603921 | 6480464 | Cyclosporine results in increased expression of SLAIN1 mRNA | CTD | PMID:20106945 | diarsenic trioxide | decreases expression | ISO | RGD:1603921 | 6480464 | Arsenic Trioxide results in decreased expression of SLAIN1 mRNA | CTD | PMID:26705709 | dorsomorphin | multiple interactions | ISO | RGD:1603921 | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | doxorubicin | decreases expression | ISO | RGD:1603921 | 6480464 | Doxorubicin results in decreased expression of SLAIN1 mRNA | CTD | PMID:29803840 | epoxiconazole | decreases expression | ISO | RGD:1318509 | 6480464 | epoxiconazole results in decreased expression of SLAIN1 mRNA | CTD | PMID:35436446 | fenvalerate | increases expression | EXP | | 6480464 | fenvalerate results in increased expression of SLAIN1 mRNA | CTD | PMID:30307764 | folic acid | decreases expression | ISO | RGD:1318509 | 6480464 | Folic Acid results in decreased expression of SLAIN1 mRNA | CTD | PMID:25629700 | formaldehyde | decreases expression | ISO | RGD:1603921 | 6480464 | Formaldehyde results in decreased expression of SLAIN1 mRNA | CTD | PMID:23649840 | gallic acid | increases expression | ISO | RGD:1603921 | 6480464 | Gallic Acid results in increased expression of SLAIN1 mRNA | CTD | PMID:34408198 | methyl methanesulfonate | decreases expression | ISO | RGD:1603921 | 6480464 | Methyl Methanesulfonate results in decreased expression of SLAIN1 mRNA | CTD | PMID:23649840 | Muraglitazar | decreases expression | EXP | | 6480464 | muraglitazar results in decreased expression of SLAIN1 mRNA | CTD | PMID:21515302 | paracetamol | increases expression | ISO | RGD:1603921 | 6480464 | Acetaminophen results in increased expression of SLAIN1 mRNA | CTD | PMID:26690555 | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of SLAIN1 mRNA | CTD | PMID:33387578 | phenylmercury acetate | decreases expression | ISO | RGD:1603921 | 6480464 | Phenylmercuric Acetate results in decreased expression of SLAIN1 mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | ISO | RGD:1603921 | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLAIN1 mRNA | CTD | PMID:27188386 | potassium chromate | increases expression | ISO | RGD:1603921 | 6480464 | potassium chromate(VI) results in increased expression of SLAIN1 mRNA | CTD | PMID:22714537 | progesterone | decreases expression | ISO | RGD:1603921 | 6480464 | Progesterone results in decreased expression of SLAIN1 mRNA | CTD | PMID:21540246 | SB 431542 | multiple interactions | ISO | RGD:1603921 | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | sodium arsenite | increases expression | ISO | RGD:1603921 | 6480464 | sodium arsenite results in increased expression of SLAIN1 mRNA | CTD | PMID:34032870 | sunitinib | increases expression | ISO | RGD:1603921 | 6480464 | Sunitinib results in increased expression of SLAIN1 mRNA | CTD | PMID:31533062 | temozolomide | increases expression | ISO | RGD:1603921 | 6480464 | Temozolomide results in increased expression of SLAIN1 mRNA | CTD | PMID:31758290 | Tesaglitazar | decreases expression | EXP | | 6480464 | tesaglitazar results in decreased expression of SLAIN1 mRNA | CTD | PMID:21515302 | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of SLAIN1 mRNA | CTD | PMID:23411599 | trichostatin A | decreases expression | ISO | RGD:1603921 | 6480464 | trichostatin A results in decreased expression of SLAIN1 mRNA | CTD | PMID:24935251, PMID:26272509 | trichostatin A | multiple interactions | ISO | RGD:1603921 | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLAIN1 mRNA | CTD | PMID:27188386 | troglitazone | decreases expression | EXP | | 6480464 | troglitazone results in decreased expression of SLAIN1 mRNA | CTD | PMID:21515302 | valproic acid | increases expression | ISO | RGD:1603921 | 6480464 | Valproic Acid results in increased expression of SLAIN1 mRNA | CTD | PMID:29154799 | valproic acid | affects expression | ISO | RGD:1603921 | 6480464 | Valproic Acid affects the expression of SLAIN1 mRNA | CTD | PMID:25979313 | valproic acid | decreases methylation | ISO | RGD:1603921 | 6480464 | Valproic Acid results in decreased methylation of SLAIN1 gene | CTD | PMID:29154799 | |